Kiora Pharmaceuticals, Inc. (KPRX) Financials

KPRX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 21.2 million 7.3 million
Dec. 31, 2025 24.3 million 8.1 million
Sept. 30, 2025 29.9 million 7.5 million
June 30, 2025 31.9 million 9.8 million

KPRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.2 million 209510
Dec. 31, 2025 -2.3 million 234448
Sept. 30, 2025 -1.3 million 254398
June 30, 2025 -3.8 million 262774

KPRX Net Income

No data available :(

KPRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 13.9 million 195369 -
Dec. 31, 2025 17.1 million 203798 368259
Sept. 30, 2025 19.4 million - 404165
June 30, 2025 20.7 million - 430406

KPRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.2 million
Dec. 31, 2025 4.1 million
Sept. 30, 2025 4.4 million
June 30, 2025 4.0 million

KPRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5018 2.1 million 1.6 million -
Dec. 31, 2025 78163 1.2 million 1.5 million -
Sept. 30, 2025 432 1.1 million 1.4 million -
June 30, 2025 32195 904572 1.4 million -

KPRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 41979
Dec. 31, 2025 - 10508
Sept. 30, 2025 - 38235
June 30, 2025 - 31496

KPRX

Price: $2.53

52 week price:
1.77
3.78

Earnings Per Share: -2.64 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 47600

Market Capitalization: 11.7 million

Links: